Evidence map›Paper›PMID 31311182›Full record

ReviewMolecules (Basel, Switzerland)2019

Biotechnological Advances in Resveratrol Production and its Chemical Diversity.

Samir Bahadur Thapa, Ramesh Prasad Pandey, Yong Il Park, Jae Kyung Sohng

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. AFrontiers in plant science · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Samir Bahadur ThapaDepartment of Life Science and Biochemical Engineering, Sun Moon University, Chungnam 31460, Korea.
Ramesh Prasad PandeyDepartment of Life Science and Biochemical Engineering, Sun Moon University, Chungnam 31460, Korea.
Yong Il ParkDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 14662, Korea. yongil382@catholic.ac.kr.
Jae Kyung SohngDepartment of Life Science and Biochemical Engineering, Sun Moon University, Chungnam 31460, Korea. sohng@sunmoon.ac.kr.
Sun Moon University · KRCatholic University of Korea · KR

Funding

National Research Foundation of Korea 2017R1C1B5018056Next-Generation BioGreen 21 Program PJ013137Next-Generation BioGreen 21 Program PJ013206
6 · The paper itself

Abstract

The very well-known bioactive natural product, resveratrol (3,5,4'-trihydroxystilbene), is a highly studied secondary metabolite produced by several plants, particularly grapes, passion fruit, white tea, and berries. It is in high demand not only because of its wide range of biological activities against various kinds of cardiovascular and nerve-related diseases, but also as important ingredients in pharmaceuticals and nutritional supplements. Due to its very low content in plants, multi-step isolation and purification processes, and environmental and chemical hazards issues, resveratrol extraction from plants is difficult, time consuming, impracticable, and unsustainable. Therefore, microbial hosts, such as

Indexed as

Biosynthetic PathwaysCorynebacterium glutamicumEscherichia coliMetabolic EngineeringMolecular StructurePlant ProteinsPlantsResveratrolSaccharomyces cerevisiaeSynthetic BiologyPlant ProteinsResveratrolchemical diversitymetabolic engineeringmicrobial productionresveratrol

Identifiers

PMID31311182
PMCPMC6680439
OpenAlexW2958719477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.